Shortage Of Creon (pancreatic Extract) Capsules Extended
Summary Creon pancreatic extract capsules in 25,000 unit and 35,000 unit strengths will have limited supply across Australia until 30 June 2026. The shortage is due to supply constraints affecting the manufacturer's ability to produce these products. This affects all Australian consumers who use these particular strengths of Creon.
- Reason
- Supply constraints will apply to Creon 25,000 unit and 35,000 unit capsules until 30 June 2026.
- Classification
- Class III
- Category
- drug recall
- Country
- Australia
- Agency
- Therapeutic Goods Administration
- Recall date
- 2025-12-17
- Status
- Ongoing
- Distribution
- Australia-wide
Official recall notice from Therapeutic Goods Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/47bf26c2-7219-4915-9e59-e57ee64aad2c